1. US plans massive coronavirus vaccine testing effort to meet year-end deadline  The Edge Markets MY
  2. Take Five: Coronavirus vaccine race is on  Investing.com
  3. Mobius Says Covid-19 Vaccine Isn't the Answer to Recovery  Bloomberg Markets and Finance
  4. Doctor testing Moderna vaccine says it's 'simply mind-boggling' that injection may be ready in 2020  CNBC
  5. A Vaccine With a Poison Pill  Bloomberg
  6. View Full coverage on Google News

CHICAGO (Reuters) - The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.CHICAGO (Reuters) - The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine candidates in an effort to deliver a safe and effective one by the end of 2020, scientists leading the program told Reuters.

Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline | The Star

403 Forbidden

Bloomberg - Are you a robot?

We may be harder to persuade than we were in the polio vaccine days.We may be harder to persuade than we were in the polio vaccine days.

Column: When we have a coronavirus vaccine, will we want to use it? - Chicago Tribune

Will vaccine for COVID-19 play into the developing narrative of seeing a shift of technological and scientific innovation from the Global North to the Global South? Or will the race simply re-instate the Cold War notion of Western world dominance?Will COVID vaccine shift narrative in technological & scientific innovation from Global North to Global South? 

Will India Overtake China As Global Power If It Wins the Vaccine Race? | OPINION

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

Analysis: Get ready for the vaccine — they’re never simple

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews”

Evan Davis on Twitter: "Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews"

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

“5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS”

Mariana Mazzucato on Twitter: "5 articles I wrote on the economic lessons from COVID19 On State Capacity https://t.co/TVrNR0z16o Doing Capitalism Differently https://t.co/EQ311xv0bm Triple Crisis https://t.co/fsrO2ReuHR) A Vaccine for All https://t.co/O6nY5pu2g1 Big Pharma Must Change https://t.co/Rrp7UibdyS"

Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.Skeptics are questioning the biotech's recent coronavirus vaccine-related announcements.

Why Moderna Stock Dropped Thursday | The Motley Fool

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...

US plans massive COVID-19 vaccine testing effort to meet year-end deadline - CNA

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

Dr. Anthony Fauci made a series of positive comments about Moderna's early COVID-19 vaccine data on Thursday night and Friday morning, sending s... Dr. Anthony Fauci made a series of positive comments about Moderna's early COVID-19 vaccine data on Thursday night and Friday morning, sending s...

Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data 'quite promising' (MRNA) | Markets Insider

Vaccine developers have four major strategies in their efforts to make a coronavirus vaccine: gene-based, adenovirus vectors, inactivated, and protein subunit. All have pros and cons, both around how they provide protection from a virus and how they’re manufactured.There are other options if they don’t work.

Unproven strategies lead the race for a COVID-19 vaccine - The Verge

Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.Operation Warp Speed's funding of AstraZeneca is intended to deliver a COVID-19 vaccine by October, although some call that timeline unrealistic.

Doubts greet $1.2 billion bet by United States on a coronavirus vaccine by October | Science | AAAS

Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.

Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.

A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says - Barron's

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine | InvestorPlace

As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...

US Top Health Expert Fauci Explains Risks Behind Development of COVID-19 Vaccine - Sputnik International

Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.

Moderna CEO and other execs made millions on vaccine announcement - CBS News

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

Moderna provides cursory glance at first COVID-19 vaccine data

Dr. Anthony Fauci said that he's "cautiously optimistic" about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is one of Moderna's partners on the COVID-19 drug, but the agency has been quiet this week on the heels of Moderna's ...Dr. Anthony Fauci said that he’s “cautiously optimistic” about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is …

Dr. Fauci has some good news about a coronavirus vaccine – BGR

NoCookies | The Australian

Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…Early morning on May 18, Moderna, a biotechnology company, revealed the preliminary findings for the much anticipated phase I trial of an mRNA COVID-19 vaccine. The information sent Moderna’s stock soaring by more than 20% and helped fuel a rally on…

The first coronavirus vaccine trial was "promising," but what does that really mean?

Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.

Covid-19: US plans massive coronavirus vaccine testing effort to meet year-end deadline - News | Khaleej Times

There's encouraging news from the two leading experimental coronavirus vaccine trials. Researchers in both trials have reported the presence of antibodies in volunteers after injecting them with experimental vaccines. Charlie D'Agata reports in the series "Racing to a Cure."There's encouraging news from the two leading experimental coronavirus vaccine trials. Researchers in both trials have reported the presence of antibodies in volunteers after injecting them with experimental vaccines. Charlie D'Agata reports in the series "Racing to a Cure."

Preliminary results from two leading vaccine trials show promise [Video]

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

Researchers, on Friday, have claimed that a vaccine developed in China appears to be safe and may protect people from coronavirus. As per reports, those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks while the antibodies needed immunity peaked at 28 days after inoculation. The trials were reportedly conducted by researchers at several laboratories and included 108 participants aged 18-60. Dr Daniel Barouch, director of vaccine researchResearchers, on Friday, have claimed that a vaccine developed in China appears to be safe and may protect people from coronavirus. As per reports, those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks while the antibodies needed immunity peaked at 28 days after inoculation.

Vaccine developed in China appears to be safe, may protect people from coronavirus: Report | World News – India TV

A coronavirus vaccine might be the door out of this hell. What if our neighbors refuse to walk through it?As the COVID-19 pandemic has unwound around the world and in North Texas, there's been a pot of gold at the end of the rainbow. The only surefire way out of our new confines, according to epidemiologists and public health officials, is researchers finding a vaccine for the novel coronavirus...

What If Texans Won't Get a Coronavirus Vaccine? | Dallas Observer

 To deal decisively with Covid-19, there is an urgent need for two items in the doctor's inventory - a vaccine and a cure.. Read more at straitstimes.com.Health News - To deal decisively with Covid-19, there is an urgent need for two items in the doctor's inventory - a vaccine and a cure.. Read more at straitstimes.com.

Singapore's search for a cure and vaccine for Covid-19, Health News & Top Stories - The Straits Times

About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.About 2.4 million Americans filed for unemployment last week. And we're in for an extremely active hurricane season. It's Thursday's news.

Coronavirus, vaccine, Michigan flooding, Ford, unemployment: Thursday's news

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

It feels like our only hope against coronavirus, so...when will a COVID-19 vaccine be ready? Experts explain the development timeline from start to finish.Be prepared for a long wait.

When will a COVID-19 vaccine be ready? Be ready to wait | Well+Good

FoxNews.com

404 | Fox News

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka. <p>In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka.</p>

Vaccine expert Peter Hotez reveals 3 things to help Houston reopen, avoid second surge of COVID-19 - HoustonChronicle.com

The Hill on Friday spoke with Anthony Fauci, director of the National InstitThe Hill on Friday spoke with Anthony Fauci, director of the National Instit

READ: The Hill's interview with Anthony Fauci | TheHill

The Hill on Friday spoke with Anthony Fauci, director of the National InstitThe Hill on Friday spoke with Anthony Fauci, director of the National Instit

READ: The Hill's interview with Anthony Fauci | TheHill

Access Denied

Less than two-thirds of Americans are "very" or "somewhat" interested in getting a COVID-19 vaccine if one becomes available, according to a Reuters/Ipsos...Less than two-thirds of Americans are "very" or "somewhat" interested in getting a COVID-19 vaccine if one becomes available, according to a Reuters/Ipsos...

Poll finds many Americans wary of taking coronavirus vaccine: report - MarketWatch

Dr. Fauci expressed confidence in a new vaccine being developed by a Massachusetts firm

Coronavirus vaccine for United States possible by December, Dr. Anthony Fauci says; ‘I think it is conceivable’ - masslive.com

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill